CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited (CHJTF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
chjtf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - General · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CSPC Pharmaceutical Group LimitedYou CHJTF | $12.0B | 18.29x | -68.6% | $0.33 |
 Alibaba Health Information Technology Limited ALBBY | $7.3B | 29.76x | -48.9% | $2.33 |
 Bangkok Dusit Medical Services Public Company Limited BDUUY | $10.0B | 20.12x | -65.4% | $38.24 |
 Swedish Orphan Biovitrum AB (publ) BIOVF | $16.4B | 234.66x | +303.2% | $1.38 |
 Eurofins Scientific SE ERFSF | $12.7B | 23.65x | -59.4% | $2.64 |
 Grifols, S.A. GIFLF | $7.6B | 16.98x | -70.8% | $0.58 |
 Olympus Corporation OCPNF | $12.3B | 24.00x | -58.8% | $61.70 |
Industry Average 6 peers with valid PE | — | 58.20x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CSPC Pharmaceutical Group Limited (CHJTF) measures how much investors pay for each dollar of the company's trailing earnings. CHJTF's current PE ratio of 18.29x is calculated by dividing its stock price of $1.05 by its TTM earnings per share of $0.33.
Frequently asked questions
CHJTF pe ratio · 6 questionsCHJTF's current PE ratio is 18.29x as of 2026-06-09, based on a stock price of $1.05 and TTM EPS of $0.33. Data sourced from Financial Modeling Prep via CHJTF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CSPC Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09